1. Cragoe Jr., E.J., Schultz E.M., Schneeberg J.D., Stokker G.E., Woltersdorf Jr., O.W., Fanelli Jr., G.M. and Watson L.S. (1975). J. Med. Chem., (1-oxo-2-substituted-5-indanyloxy) acetic acids, A new class of potent renal agents possessing both uricosuric and saluretic activity. A reexamination of the role of sulfhydryl binding in the mode of action of acylphenoxyacetic acid saluretics,18, 225–228.
2. Woltersdorf Jr., O.W., Cragoe Jr., E.J. and Watson L.S. Synthesis and evaluation of (1-oxo-2-substituted-5-indanyloxy) acetic acids as novel uricosuric diuretics, 169th National American Chemical Society Meeting, Philadelphia, Pa., April, 1975, Medicinal Chemistry Division Paper No. 48.
3. Woltersdorf Jr., O.W., Schneeberg J.D., Schultz E.M., Stokker G.E., Cragoe Jr., E.J., Watson L.S. and Fanelli Jr., G.M. (1-Oxo-2,2-dialkyl-and 1-oxo-2-alkyl-2-aryl-5-indanyloxy) acetic acids, A new class of uricosuric saluretics, 169th National American Chemical Society Meeting, Philadelphia, Pa., April, 1975, Medicinal Chemistry Division Paper No. 49.
4. Watson L.S. and Fanelli Jr., G.M. (1975). Fed. Proc., Saluretic and uricosuric effects of a new indanone34, 802.
5. Watson L.S., Fanelli Jr., G.M., Russo H.F., Sweet C.S., Ludden C.T. and Scriabine A. (1976). New Antihypertensive Drugs; Sweet C.S. and Scriabine A., Editors, Spectrum Publishers, Inc., Halliswood, N.Y. (in press, 1976).